Impact of serum caffeine monitoring on adverse effects and chemotherapeutic responses to caffeine-potentiated chemotherapy for osteosarcoma.
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association2009Hayashi K, Tsuchiya H, Yamamoto N, et al.
抄録
cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。
MeSH
AdolescentAdultAntineoplastic Combined Chemotherapy ProtocolsBiomarkersCaffeineChildChild, PreschoolCisplatinDisease-Free SurvivalDose-Response Relationship, DrugDoxorubicinDrug SynergismFemaleHumansInfusions, Intra-ArterialMaleMiddle AgedOsteosarcomaYoung Adult
DOI 10.1007/s00776-009-1336-9
PMID 19499290
原文・出典を見る →